AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.45
-0.08 (-0.76%)
At close: May 22, 2026, 4:00 PM EDT
10.45
0.00 (0.00%)
After-hours: May 22, 2026, 4:10 PM EDT
AdaptHealth Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, AdaptHealth stock has a consensus rating of "Buy" and an average price target of $14. The average 1-year stock price forecast is 33.97% higher than the current stock price, while the lowest is $11 (+5.26%) and the highest is $18 (+72.25%).
Price Target: $14 (+33.97%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AdaptHealth stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 3 |
| Buy | 2 | 2 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $13 → $15 | Buy | Maintains | $13 → $15 | +43.54% | May 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +53.11% | May 6, 2026 |
| UBS | UBS | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +33.97% | May 6, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +33.97% | Apr 13, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +14.83% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
3.56B
from 3.24B
Increased by 9.62%
Revenue Next Year
3.79B
from 3.56B
Increased by 6.47%
EPS This Year
0.90
from -0.52
EPS Next Year
1.23
from 0.90
Increased by 37.53%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.7B | 4.0B | |
| Avg | 3.6B | 3.8B | |
| Low | 3.4B | 3.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.3% | 11.6% | |
| Avg | 9.6% | 6.5% | |
| Low | 4.2% | -0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.17 | 1.56 | |
| Avg | 0.90 | 1.23 | |
| Low | 0.62 | 0.98 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 74.5% | |
| Avg | - | 37.5% | |
| Low | - | 9.3% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.